IBSynergy (60 caps) by Designs for Health

Product Size: 60 vegetarian capsules
Serving Size: 2 capsules

Change description: IBSynergy™ is now one word (without the space) to highlight this formula’s primary application and target patient population, those with common IBS-C related complaints.* The new tagline is “Supports Healthy Gut Motility* indicating its role in bowel regularity for those with occasional constipation.*

Product description:
This synergistic combination of perilla extract, 5-hydroxytryptophan, L-glutamine, and an active dried yeast is formulated to promote healthy gut motility for normal bowel movements, gastrointestinal function, and a healthy gut-brain axis connection.*

Recommended Use: Take 2 capsules per day (preferably on an empty stomach).*

*This product is not intended to diagnose, treat or cure any illness or disease. The content and recommendations contained on this website have not been reviewed by the U.S. Food and Drug Administration (FDA) and are solely the opinion of the authors. Content contained on this website is not a substitute for professional medical advice, diagnosis or treatment. Never increase, reduce or discontinue any medication or treatment without first consulting your doctor.*

Disclaimer††An IPSOS 2023 survey among US functional medicine practitioners, in an average month, Designs for Health is their personally most trusted practitioner supplement brand, meaning a brand that is sold by healthcare practitioners in their office.††An Ipsos 2023 study among a random sample of 160 functional medicine practitioners including Doctor’s of Osteopathic Medicine, Pharmacists, Acupuncturists, Athletic Trainers, Personal Trainers, Fitness Trainer/Coaches, Chiropractors, Integrative Medicine Specialists, Naturopathic Doctor, Homeopaths, Medical Doctors, Physical Therapists, Nurse Practitioner/Physician Assistants, Registered Nurses, Nutritionists, Massage Therapists, Occupational Therapists and Dieticians that are aware of Designs for Health and recommend supplements to their patients.**